| 000 | 00971 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250511204453.0 | ||
| 264 | 0 | _c19920409 | |
| 008 | 199204s 0 0 eng d | ||
| 022 | _a0147-958X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEpstein, M | |
| 245 | 0 | 0 |
_aCalcium antagonists and renal hemodynamics: implications for renal protection. _h[electronic resource] |
| 260 |
_bClinical and investigative medicine. Medecine clinique et experimentale _cDec 1991 |
||
| 300 |
_a590-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney _xblood supply |
| 650 | 0 | 4 |
_aKidney Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aVasoconstriction _xdrug effects |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 773 | 0 |
_tClinical and investigative medicine. Medecine clinique et experimentale _gvol. 14 _gno. 6 _gp. 590-5 |
|
| 999 |
_c1800436 _d1800436 |
||